Inhibition of a G9a/DNMT network triggers an immune-mediated bladder cancer regression treated with CM272 (IC50)

ABSTRACT: Based on the identification of G9a as a potential target in BC, we decided to test the effect of a recently described dual inhibitor against G9a/DNMTs, CM-272, in several BC cell lines

ORGANISM(S): Homo sapiens

PROVIDER: GSE115544 | GEO | 2019/02/01

REPOSITORIES: GEO